CROI 2024 Program Guide

Poster Sessions

CMV Viraemia Is Associated With Mortality Among Children With HIV Starting ART in Sub-Saharan Africa Temitope Fisayo , Ceri Evans, Kuda Mutasa, Moira Spyer, Sandra Rukobo, Dagmar Alber, Mutsawashe Bwakura-Dangarembizi, Victor Musiime, Kusum Nathoo, Adeodata R Kekitiinwa, Cissy Kityo, Diana Gibb, Nigel Klein, Sarah Walker, Andrew Prendergast Sex Differences in Growth Trajectories Between Early-Treated Infants With HIV and Controls Ana Barrios-Tascon , Renate Strehlau, Faeezah Patel, Megan Burke, Stephanie Shiau, Yanhan Shen, Stephen M Arpadi, Elaine J Abrams, Caroline T Tiemessen, Louise Kuhn, for the LEOPARD Study Team 1 in 5 Sub-Saharan Infants Switches From Undetectable to Detectable HIV Viral Load During Follow-Up Sheila Fernández-Luis, Sara Dominguez-Rodriguez, Louise Kuhn, Mark F Cotton, Carlo Giaquinto, Paolo Rossi, Anita Janse van Rensburg, Avy Violari, Maria Grazia Lain, Elisa López-Varela, Mariam Sylla, Pauline Amugue, Pablo Rojo, Alfredo Tagarro , for EPIICAL Causes of Death After Early ART in Infants Living With HIV From 3 Sub-Saharan African Countries Alfredo Tagarro , Sheila Fernández-Luis, Sara Dominguez-Rodriguez, Alvaro Ballesteros, Louise Kuhn, Mark F Cotton, Carlo Giaquinto, Paolo Rossi, Moira Spyer, Kennedy Otwombe, Osee Behuhuma, Paula Vaz, Caroline Foster, Pablo Rojo, for EPIICAL Usefulness of Clinical Signs for Tuberculosis Diagnosis in Infants Living With HIV With Pneumonia Tisungane Mvalo , Cinta Moraleda, William C Buck, Victor Musiime, Sara Dominguez-Rodriguez, Chishala Chabala, Hilda A Mujuru, Alfredo Tagarro, Pui-Ying Iroh Tam, Jahit Sacarlal, Abner Tagoola, John Tembo, Sheila Fernández-Luis, Pablo Rojo, for the EMPIRICAL Clinical Trial Group No Early Signal That DTG Improves 24-Week Viral Suppression in Infants in Botswana Maureen Sakoi-Mosetlhi , Gbolahan Ajibola, Oganne Batlang, Kenneth Maswabi, Molly Pretorius Holme, Kathleen M Powis, Shahin Lockman, Michael D Hughes, Joseph M Makhema, Daniel R Kuritzkes, Mathias Lichterfeld, Roger Shapiro HIV Viral Suppression Among Children and Adolescents 2 Years After Transition to Dolutegravir Akash Devendra, Maurus Kohler, Motlatsi Letsika, Hape Khooa, Lipontšo Motaboli, Malebanye Lerotholi, Nadine Tschumi, Niklaus D. Labhardt , Jennifer A Brown Longitudinal Viral Outcomes in Kenyan Youth With HIV Switching to Dolutegravir-Based Therapy Vlad Novitsky , Winstone Nyandiko, Allison DeLong, Edwin Sang, Joel Hague, Ashley Chory, Josephine Aluoch, Eslyne Jepkemboi, Millicent Orido, Joseph Hogan, Rachel Vreeman, Rami Kantor

962 NIS

963

Poster Sessions • Tuesday

964

965

966

Poster Session-P6 | Pediatric Antiretroviral Therapy Optimization: Dolutegravir in Action 2:30 PM - 4:00 PM • Poster Hall C-D

981 NIS

982

983

CROI 2024 133

New Investigator Scholarship

LB

NIS

Late-Breaking